­

SMA Genetic Testing and IVF Could Save Over $3.8M per Patient

With Novartis’ new treatment for spinal muscular atrophy (SMA) projected to exceed $4 million per patient, Dr. Mark Trolice of Fertility CARE: The IVF Center advocates for genetic tests and IVF that can prevent the disease at 1/25 the cost.

(Orlando, FL) February 4, 2019 – Pharmaceutical company Novartis made headlines in 2018 with a new […]